DHCNL Diversified Healthcare Trust - 6.25% Senior Notes Due 2046
NASDAQ · Real Estate · View on SEC EDGAR ↗ close Oct 5, 2026 10-K/10-Q Aug 3, 2026DHCNL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DHCNL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DHCNL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 2.6 | · | 1.7 | Overvalued | |
| Price / Tangible Book (MRQ) | 2.7 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Aug 14, 2026 | $0.39 | USD | ≈4.2% |
| May 15, 2026 | $0.39 | USD | ≈2.0% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.16 | $-0.15 | -5.6% | |
| March 31, 2026 | $-0.18 | $-0.16 | -13.8% | |
| Dec. 31, 2025 | $-0.09 | $-0.18 | 49.1% | |
| Sept. 30, 2025 | $-0.68 | $-0.22 | -213.1% | |
| June 30, 2025 | $-0.38 | $-0.22 | -71.0% | |
| March 31, 2025 | $0.05 | $-0.22 | 122.5% | |
| Sept. 30, 2024 | $0.02 | $-0.26 | 107.6% | |
| Sept. 30, 2023 | $0.03 | $-0.21 | 114.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Revenue | $365M | $383M | |
| SG&A Expense | $19M | $11M | |
| Operating Expenses | $366M | $421M | |
| Pretax Income | $-38M | $-94M | |
| Income Tax | $1M | $843.0K | |
| Net Income | $-37M | $-92M | |
| EPS (Basic) | $-0.16 | $-0.38 | |
| EPS (Diluted) | $-0.16 | $-0.38 | |
| Shares (Basic) | 240,749,000 | 240,132,000 | |
| Shares (Diluted) | 240,749,000 | 240,132,000 | |
| EBITDA | $63M | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Cash & Equivalents | $117M | · | |
| Intangibles | $18M | · | |
| Total Assets | $4.24B | · | |
| Total Liabilities | $2.66B | · | |
| Long-term Debt | $2.44B | · | |
| Common Stock | $2M | · | |
| Retained Earnings | $1.04B | · | |
| AOCI | $-55.0K | · | |
| Stockholders' Equity | $1.58B | · | |
| Liabilities + Equity | $4.24B | · | |
| Shares Outstanding | 242,189,353 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| D&A | $63M | $66M | |
| Operating Cash Flow | $38M | · | |
| Investing Cash Flow | $-39M | · | |
| Stock Repurchased | $50.0K | · | |
| Dividends Paid | $2M | · | |
| Financing Cash Flow | $-3M | · | |
| Net Change in Cash | $-4M | · |
Profitability
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Net Margin | -10.2% | · | |
| Pretax Margin | -10.4% | · | |
| EBITDA Margin | 17.1% | · | |
| ROA | -0.83% | · | |
| ROE | -2.2% | · |
Efficiency
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Asset Turnover | 0.1 | · |
Per Share
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Book Value / Share | $6.54 | · | |
| Revenue / Share | $1.52 | · | |
| Cash / Share | $0.48 | · | |
| Dividend / Share | $0.01 | · | |
| EPS (TTM) | $-1.11 | $-1.20 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Revenue TTM | $1.50B | $1.52B | |
| Net Income TTM | $-266M | $-287M | |
| Market Cap | $4.38B | · | |
| P/E | -16.3 | · | |
| P/S | 2.9 | · | |
| P/B | 2.8 | · | |
| P / Tangible Book | 2.8 | · | |
| Dividend Yield | 0.22% | · | |
| Earnings Yield | -6.1% | · | |
| Annual Payout | $10M | $10M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| H/2 Special Opportunities IV L.P., HABER SPENCER B | Aug. 12, 2026 | 4.98% | Amendment | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 8 insiders · 2 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Christopher J. Bilotto | President and CEO | Sept. 17, 2026 F | 314,067 | 0 | 0 | $0 |
| Matthew C. Brown | CFO and Treasurer | Sept. 17, 2026 F | 153,109 | 0 | 0 | $0 |
| Adam D. Portnoy | Director | Sept. 17, 2026 F | 467,924 | 0 | 0 | $0 |
| Alan L. Felder | Director | June 10, 2026 A | 75,124 | 0 | 0 | $0 |
| Dawn K. Neher | Director | June 10, 2026 A | 78,579 | 0 | 0 | $0 |
| Lisa Harris Jones | Director | June 10, 2026 A | 170,287 | 0 | 0 | $0 |
| Jeffrey P. Somers | Director | June 10, 2026 A | 177,079 | 0 | 0 | $0 |
| Phyllis M. Hollis | · | June 10, 2026 A | 100,148 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
DHCNL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DHCNL | · | · | · | · | · | · |
| HR | $5.96B | -23.9 | -6.9% | -20.8% | -5.0% | · |
| SBRA | $4.77B | 29.6 | 10.2% | 20.1% | 5.6% | · |
| NHI | $3.69B | 25.3 | 12.1% | 37.9% | 9.8% | · |
| LTC | $1.67B | 13.6 | 25.3% | 44.9% | 11.6% | · |
| MPT | $2.99B | -10.9 | -2.4% | -28.5% | -5.9% | · |
| DHC | $1.17B | -4.1 | 2.8% | -18.6% | -16.2% | · |
| UHT | $544M | 30.9 | 0.18% | 17.8% | 10.6% | · |
| XRN | $447M | -37.1 | 6.8% | -4.6% | -1.3% | · |
| CHCT | $467M | 205.2 | 4.7% | 4.2% | 1.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.